These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1226591)

  • 1. Cell-mediated immunity to isolated human oligodendroglia in multiple sclerosis.
    Myers LW; Ellison GW; Fewster ME; Wolfgram F
    Trans Am Neurol Assoc; 1975; 100():107-9. PubMed ID: 1226591
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oligodendroglia in multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure D
    Trans Am Neurol Assoc; 1977; 102():15-8. PubMed ID: 616097
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to oligodendroglia in multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1978 Mar; 298(13):743. PubMed ID: 628401
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro study of the cytotoxicity of sera from patients with multiple sclerosis and other neurological diseases to cultured rat oligodendrocytes].
    Hirayama M; Kawai K; Iida M; Sobue I
    Rinsho Shinkeigaku; 1986 Aug; 26(8):835-40. PubMed ID: 3802676
    [No Abstract]   [Full Text] [Related]  

  • 7. Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosis.
    Fewster ME; Ellison GW; Myers LW; Kirashige EY
    Neurology; 1975 Aug; 25(8):735-9. PubMed ID: 1080263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
    Bartlett PF; Mackay IR
    J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessory cell competence of ovine oligodendrocytes in mitogenic activation of human peripheral T cells.
    Cashman NR; Noronha A
    J Immunol; 1986 Jun; 136(12):4460-3. PubMed ID: 3486900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity in multiple sclerosis.
    Rysková O; Vejbora O; Chromová L; Pekárek J; Chmelar V; Zaydlar K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(1):85-91. PubMed ID: 6975970
    [No Abstract]   [Full Text] [Related]  

  • 12. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
    Scolding NJ; Morgan BP; Houston WA; Linington C; Campbell AK; Compston DA
    Nature; 1989 Jun; 339(6226):620-2. PubMed ID: 2733792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
    Sheremata W; Cosgrove JB; Robb P
    Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes.
    Ma BI; Joseph BS; Walsh MJ; Potvin AR; Tourtellotte WW
    Ann Neurol; 1981 Apr; 9(4):371-7. PubMed ID: 6452854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescent staining of rat brain glial cells with multiple sclerosis serum.
    Singh VK; Mashal RD
    Can J Neurol Sci; 1981 May; 8(2):143-5. PubMed ID: 7028233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls.
    Hirayama M; Lisak RP; Silberberg DH
    Neurology; 1986 Feb; 36(2):276-8. PubMed ID: 3945400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
    Taranova NP; Kirchik OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological aspects of demyelination.
    Steck AJ
    Bull Schweiz Akad Med Wiss; 1981-1982; ():109-12. PubMed ID: 6191816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glial migration inhibition test in multiple sclerosis patients and its changes during treatment with immunosuppressants].
    Kogan OG; Kanchurin AKh; Kuznetsova OV; Brusina LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1798-1802. PubMed ID: 7340320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathology of the nervous system. IV. Cellular components of immunopathology of the nervous system (fourth of five parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1977; 5(5):605-10. PubMed ID: 304303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.